CPMD — Cannapharmarx Cashflow Statement
0.000.00%
Last trade - 00:00- $3.18m
- $14.89m
- $0.82m
Annual cashflow statement for Cannapharmarx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -19.9 | -8.83 | -8.53 | 3.69 | -9.91 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 15.5 | 6.84 | 2.84 | -5.27 | 8.18 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.72 | -0.421 | 3.95 | -0.821 | 0.024 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.564 | -2.41 | -1.45 | -2.27 | -1.7 |
| Capital Expenditures | 0 | -0.006 | -0.116 | -0.081 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0.5 | 0 | — | — |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0.494 | -0.116 | -0.081 | 0 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.825 | 1.34 | 1.4 | 2.35 | 1.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.333 | -0.307 | -0.025 | -0.002 | 0.002 |